posted
CHHH: To Acquire 51% Stake of Xi'an Chunhui Pharmaceuticals Co. in China Tuesday , December 05, 2006 08:12 ET
By Fain Hughes, fhughes*knobias.com
China Health Holding (CHHH) announced that it has executed a binding acquisition letter of intent to acquire 51% or more ownership of Xi'an Chunhui Pharmaceuticals Co. Ltd., based in the People's Republic of China.
China Health Holding to be Added to China Small-Cap Index Dec 19, 2006 12:19:00 PM Copyright Business Wire 2006
LAS VEGAS--(BUSINESS WIRE)--
China Health Holding (OTCBB: CHHH), a developer, manufacturer, marketer and distributor of pharmaceutical products and dietary supplements in China and worldwide, announced today that it will be added to the Ludlow China Small-Cap Index in Jan 2007, a diversified stock index of Chinese stocks traded in the U.S. financial markets owned and operated by the New York-based investment banking firm Ludlow China Fund, Inc.
Julianna Lu, The Company's Founder and CEO said, "Ludlow's decision to add CHHH to its index of small-cap Chinese stocks is yet another indication of CHHH's increasing exposure amongst the U.S. investment community. As in all indexing, this designation will automatically introduce the CHHH investment story to new investors who are interested in 'buying the market' by duplicating the basket that the index defines -- in this case small-cap China- based stocks. Also, inclusion on a China Small-Cap Index implicitly recognizes that CHHH now has the liquidity, market capitalization and strong financial track record to be an appropriate investment for institutions with indexed portfolios."
Posts: 1343 | From: Rome Georgia | Registered: Oct 2004
| IP: Logged |
posted
All time record volume today. Hope some others got on the train today with me.
This is going to explode after the first of the year.
Holding this one very tight.
Ludlow China Fund
Ludlow China Fund, Inc. Based in New York City, the Ludlow China Fund aims to provide individual/institutional investors with a means to invest in the emerging China market through our diversified fund. The fund is also a banking source for publicly traded China based companies to distribute their corporate news, recent 10Q, 10K, and 8K filings, and private stock offerrings to our banking partners in the United States, Europe, and Asia.
About Ludlow China Index
The Ludlow China Index is a basket of some of the top US traded Chinese companies. The Index provides institutional and individual investors a gauge for tracking the day to day performance of Chinese stocks traded here in the US. The index is designed for investors who have a long-term bullish outlook on China's emerging market. The Ludlow China Index is owned and operated by Ludlow China Fund, Inc., based in New York City. www.ludlowcapital.com/china ---------------
Posts: 1343 | From: Rome Georgia | Registered: Oct 2004
| IP: Logged |
posted
Holy moly! This baby is moving! I bought higher than I wanted to yesterday.. I normally do not like buying after it's already up.. but shoot.. they're talking about this one going to .20 or higher.. and it IS looking super! Thanks for the heads-up, Jonus!
-------------------- "As long as there are dreamers, there are dreams that will come true." Posts: 862 | From: CT Yankee..... in FLA | Registered: Aug 2005
| IP: Logged |
-------------------- "As long as there are dreamers, there are dreams that will come true." Posts: 862 | From: CT Yankee..... in FLA | Registered: Aug 2005
| IP: Logged |
-------------------- "As long as there are dreamers, there are dreams that will come true." Posts: 862 | From: CT Yankee..... in FLA | Registered: Aug 2005
| IP: Logged |
-------------------- "As long as there are dreamers, there are dreams that will come true." Posts: 862 | From: CT Yankee..... in FLA | Registered: Aug 2005
| IP: Logged |
posted
.085x.09.. geeesh! Is anyone home in here? Did anyone get in? helloooooooo?
-------------------- "As long as there are dreamers, there are dreams that will come true." Posts: 862 | From: CT Yankee..... in FLA | Registered: Aug 2005
| IP: Logged |
posted
a little healthy profit taking here I suppose :-)
-------------------- "As long as there are dreamers, there are dreams that will come true." Posts: 862 | From: CT Yankee..... in FLA | Registered: Aug 2005
| IP: Logged |
China Health Holding 08-Jan-07 • NASDAQ OTC-Bulletin Board Symbol CHHH
China Health Holding Announces Acquisition of All of the Assets of Xi'An Meichen Pharmaceutical (Story 1 of 10) LAS VEGAS, Jan. 8 /Xinhua-PRNewswire-FirstCall/ -- China Health Holding, Inc. (OTC Bulletin Board: CHHH), a development stage company with the goal of becoming a developer, manufacturer, marketer and distributor of pharmaceutical products and dietary supp
Under the agreement, China Health would acquire Xi' An Meichen's new pharmaceutical manufacturing facilities - all certified for Good Manufacturing Practices (GMP) by the China State Food and Drug Administration ("China-SFDA")
along with 43 China-SFDA certified pharmaceutical drugs. China Health also will acquire real estate property totaling about 16,000 square meters. As consideration, China Health will issue 20,000,000 common shares of its restricted common stock and pay approximately US$$1,530,000 in cash to Xi'An Meichen. The conditions of closing, include, but are not limited to, the satisfactory completion of due diligence by the parties and the approval of the transaction by the shareholders holding 100% of the ownership interest of Xi'An Meichen.
Julianna Lu, Founder/CEO of China Health Holding, commented: "The acquisition contemplated by this agreement with Xi'An MeiChen Pharmaceuticals is the latest in a series of recent steps that China Health has taken to execute its ambitious comprehensive growth strategy and targets. Through this and other transactions, we are in the process of building a powerful network of established China-SFDA-certified pharmaceutical drug manufacturing facilities along with extensive hospital and drugstore distribution channels in China. We intend to also have an enhanced pipeline of hundreds of China-SFDA certified pharmaceutical drugs."
In addition to the pending Xi'An MeiChen acquisition, China Health has announced several other pending or completed acquisitions of Chinese based pharmaceutical companies in recent months. It has executed binding letters of intent to acquire 51% or more of Beijing Boran Pharmaceutical Co. Ltd., Shaanxi Wanan Pharmaceutical Co. Ltd., Xi'An Chunhui Pharmaceutical and Henan Tiankang Pharmaceutical Co. Ltd. All these letters give it legal first refusal and exclusive rights. China Health is currently conducting due diligence and acquisition transactions in connection with these pending acquisitions.
It has also executed definitive agreements for acquiring 60% of Henan Furen Huaiqingtang Pharmaceutical Co. Ltd. and 100% of Shaanxi MeiChen Pharmaceutical, Ltd. It has signed a letter of intent with WangJing Hospital and the WangJing Hospital of China Academy of Chinese Medical Sciences, to develop the China International University of Traditional Chinese Medicine and the University Hospital for Traditional Chinese Medical Sciences.
In the next 12 to 24 months, China Health plans to complete further acquisitions and transactions with major pharmaceutical companies in the People's Republic of China and worldwide, bringing its total assets to approximately US$100 million. At the end of this process, it expects internal growth and projects annual gross revenue of approximately US$100 million, with annual net income of approximately US$10 million to US$15 million.
About Xi'An Meichen Pharmaceutical
Xi'An Meichen Pharmaceutical, based in the Shaanxi Province of the People's Republic of China, is a drug manufacturer, developer and distributor with good manufacturing practices (GMP) certification from the China State Food and Drug Administration (China-SFDA). It manufactures and distributes a total of 43 China-SFDA certified herbal-based drugs and chemical-based drugs to China-SFDA licensed hospitals and drugstores across Shaanxi province and the People's Republic of China. It owns a new, 16,000-square-meter China-SFDA certified pharmaceutical facility with the capacity to produce herbal and chemical drugs in a number of forms -- abstraction, pills, granules, capsules (soft and hard), powders, drops, etc... It also owns one China-SFDA certified pharmaceutical herbal/raw materials cultivation base.
Xi'an Meichen's Pharmaceutical's herbal based and chemical-based pharmaceutical drugs are used in treatment of cardio-cerebral vascular disease, stomach disease, conjunctivitis, acute and chronic gastritis, gastric ulcer, erosive gastritis, duodenal ulcer, gastric hemorrhage, bronchial asthma, asthmatic bronchitis, insomnia headache and fever.
About China Health Holding
China Health Holding, Inc., a development stage company with the goal of becoming a developer, manufacturer, marketer and distributor of pharmaceutical products and dietary supplements in China and worldwide. The Company has extensive expertise in the field of traditional Chinese medicine and the Chinese pharmaceutical industry. Its immediate goal is the profitable penetration of the growing global and China pharmaceutical industry and market through acquisitions of major pharmaceutical companies in the People's Republic of China and worldwide. Its long-term plans include the development of a pharmaceutical drug pipeline and technology based on its knowledge of traditional Chinese medicine and the pharmaceutical industry in the People's Republic of China.
The company has two wholly-owned subsidiaries: (i) China Health World Pharmaceutical Corporation, which will develop, manufacture and commercialize natural medications for diseases and conditions related to diabetes, cardiovascular disease and neurological disorders; and (ii) China Health World Trade Corporation, which will develop China Health's retail/franchise infrastructure along with worldwide branding, multimedia marketing and multi-channel distribution to global customers and markets.
China Health owns the exclusive worldwide rights to a total of 134 proprietary natural herbal medicinal products/formulas in two natural herbal medicinal product lines: King of Herbs and Taoist Medicinal. Please visit http://www.chinahealthholding.com for the Company's profile.
Safe Harbor Statement: To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company's press releases to reflect events or circumstances after the date hereof.
SOURCE China Health Holding, Inc.
Posts: 4071 | Registered: Dec 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Cool]](cool.gif)
